Eva Barragán
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 66
- Acute Myeloid Leukemia Research 59
- Chronic Myeloid Leukemia Treatments 16
-
- Retinoids in leukemia and cellular processes 23
- Protein Degradation and Inhibitors 6
- Co-authors
- Miguel Á. Sanz (55 shared papers)Pascual Bolufer (43 shared papers)José Cervera (36 shared papers)Guillermo Martı́n (12 shared papers)Esperanza Such (23 shared papers)Mariam Ibáñez (16 shared papers)Pascual Fernández (3 shared papers)Ana Valencia (10 shared papers)
- Journals
- Leukemia Research (7 papers)Cancers (5 papers)Annals of Hematology (5 papers)Clinica Chimica Acta (4 papers)Blood (3 papers)
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
Eva Barragán
88 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 81
- Hematology 936
- Genetics 283
- Cancer Research 251
- Molecular Biology 1.1k
- Public Health, Environmental and Occupational Health 395
Countries citing papers authored by Eva Barragán
This map shows the geographic impact of Eva Barragán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Barragán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Barragán more than expected).
Fields of papers citing papers by Eva Barragán
This network shows the impact of papers produced by Eva Barragán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Barragán. The network helps show where Eva Barragán may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Barragán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. | 2003 | 146 |
| 2 | 2009 | 120 | |
| 3 | Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. | 2004 | 100 |
| 4 | 2020 | 93 | |
| 5 | 2006 | 76 | |
| 6 | 2007 | 66 | |
| 7 | 2010 | 53 | |
| 8 | 2007 | 51 | |
| 9 | 2011 | 39 | |
| 10 | 2016 | 38 | |
| 11 | 1997 | 36 | |
| 12 | 2008 | 36 | |
| 13 | 2013 | 36 | |
| 14 | 2006 | 32 | |
| 15 | 2013 | 31 | |
| 16 | Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes. | 2000 | 31 |
| 17 | Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols. | 2001 | 29 |
| 18 | 1999 | 28 | |
| 19 | 2008 | 28 | |
| 20 | 2001 | 26 |
About Eva Barragán
Eva Barragán is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Genetics, having authored 92 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (59 papers), Acute Lymphoblastic Leukemia research (24 papers), Retinoids in leukemia and cellular processes (23 papers), Chronic Myeloid Leukemia Treatments (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Cancer Genomics and Diagnostics (9 papers), BRCA gene mutations in cancer (8 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (936 citations), Genetics (283 citations), Cancer Research (251 citations), Molecular Biology (1.1k citations) and Public Health, Environmental and Occupational Health (395 citations). Eva Barragán has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Miguel Á. Sanz, Pascual Bolufer, José Cervera, Guillermo Martı́n, Esperanza Such, Mariam Ibáñez, Pascual Fernández, Ana Valencia, Federico Moscardó and Guillermo Sanz. Their work appears in journals such as Leukemia Research, Cancers, Annals of Hematology, Clinica Chimica Acta and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.